Insulet (PODD) net assets (shareholders' equity)

Net assets · fiscal 2025
$1.52B

Insulet (PODD) had net assets of $1.52B at the end of fiscal 2025 (December 31, 2025). That is 25.1% higher than the $1.21B of fiscal 2024. Figures as of 18 Nov 2026, 23:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$1.52B
Change on fiscal 2024
+25.1%
Growth, 5 years
+20.2% a year
Growth, 10 years
+46.2% a year
Highest on record
$1.52Bfiscal 2025
Lowest on record
$34.05Mfiscal 2015
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Insulet net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 20.2% a year; over ten years the rate was 46.2% a year. Across the 17 fiscal years on record (2009–2025), the highest was $1.52B in fiscal 2025 and the lowest $34.05M in fiscal 2015.

History · 17 fiscal years

Net assets by fiscal year

Insulet net assets (shareholders' equity), year by year

Insulet (PODD) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$1.52B 25.1% up
2024$1.21B 65.4% up
2023$732.70M 53.8% up
2022$476.40M 14.4% down
2021$556.30M 7.8% down
2020$603.60M 695.3% up
2019$75.90M 64.2% down
2018$212.10M 33.8% up
2017$158.50M 151.2% up
2016$63.10M 85.3% up
2015$34.05M 59.4% down
2014$83.83M 32.7% down
2013$124.60M 182.0% up
2012$44.18M 46.6% down
2011$82.74M 24.9% up
2010$66.23M 7.0% up
2009$61.91M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Insulet and comparable companies
CompanyNet assetsFiscal year
Vaxcyte PCVX$2.69B2025
Bio-Rad Laboratories BIO$7.45B2025
Molina Healthcare MOH$4.07B2025
Spyre Therapeutics SYRE$715.24M2025
Qiagen QGEN$3.78B2025
Insulet PODD$1.52B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PODD

Insulet, figure by figure

Insulet (PODD) overview: price, valuation and scorecardAll health care companies by market value

Insulet net assets (shareholders' equity): questions and answers

What are Insulet's net assets?

Insulet (PODD) had net assets of $1.52B at the end of fiscal 2025 (December 31, 2025). That is 25.1% higher than the $1.21B of fiscal 2024.

What is the growth rate of Insulet's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 20.2% a year; over ten years the rate was 46.2% a year.

What are the highest and lowest net assets figures on record for Insulet?

Across the 17 fiscal years on record (2009–2025), the highest was $1.52B in fiscal 2025 and the lowest $34.05M in fiscal 2015.

How is Insulet's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Insulet it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insulet (PODD) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/PODD/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.